Dl-Penicillamine

Dl-Penicillamine

SCHEMBL57527

CC(C)(S)C(N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281362-B2 Diagnostic tools and treatments for clear cell renal cell carcinoma UNIVERSITY OF CINCINNATI (US) 2025-04-22 US claimed
CN-119320407-A Bone-targeting ALD/NO twin drug 温州医科大学附属口腔医院 2025-01-17 CN claimed
CN-118459535-A Polypeptide fragment connection method and polypeptide protein synthesis method 中国科学技术大学 2024-08-09 CN claimed
CN-114426441-B Method for chloridizing iron-catalyzed quinone compound 南京师范大学 2023-12-12 CN claimed
CN-113391060-B Blood sample treating agent and application thereof 北京北方生物技术研究所有限公司 2023-08-08 CN claimed
EP-3743270-B1 CAST-MOLDING PROCESS FOR PRODUCING UV-ABSORBING CONTACT LENSES ALCON INC (CH) 2022-06-08 EP claimed
US-20220136059-A1 Diagnostic Tools and Treatments for Clear Cell Renal Cell Carcinoma UNIVERSITY OF CINCINNATI (US) 2022-05-05 US claimed
CN-114426441-A Method for catalyzing chlorination of quinone compounds by iron 南京师范大学 2022-05-03 CN claimed
US-11136720-B2 Moisture-proof, fibrous substrate having adjustable moisture and wet strength, and method for production thereof CHEM&P GMBH & CO. KG (DE) 2021-10-05 US claimed
CN-113391060-A Blood sample treating agent and application thereof 北京北方生物技术研究所有限公司 2021-09-14 CN claimed
EP-0560267-B1 Isosteric antiherpes peptide derivatives BOEHRINGER INGELHEIM CA LTD (CA) 1998-08-19 EP claimed
EP-0560274-B1 Antiherpes peptide derivatives having a ureido N-terminus BOEHRINGER INGELHEIM CA LTD (CA) 1998-06-24 EP claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
JP-H08507760-A 1996-08-20 JP claimed
EP-0451760-B1 Nitrato alkanoic acid derivatives and method for their production SANOL ARZNEI SCHWARZ GMBH (DE) 1995-09-13 EP claimed
EP-0618226-A1 Inhibitors of herpes viral ribonculeotide reductase BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-10-05 EP claimed
WO-1994020528-A1 INHIBITORS OF HERPES VIRAL RIBONUCLEOTIDE REDUCTASE BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-09-15 WO claimed
WO-1993018056-A1 ISOSTERIC ANTIHERPES PEPTIDE DERIVATIVES BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-16 WO claimed
EP-0560274-A1 Antiherpes peptide derivatives having a ureido N-terminus BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed
EP-0560267-A1 Isosteric antiherpes peptide derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed